Delivery Order SPE2DB20D2104-SPE2DB24FQ77Q
- Not listed
- This is a $2,469.92 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication QULIPTA 60 MG TABLET 30S and has an ultimate completion date of July 7, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.21 delivery order contract is for the supply of QULIPTA 30 MG TABLET 30S, a pharmaceutical product. The contract has a performance period through February 27, 2024 and is priced on a firm fixed price basis. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,697.75 firm-fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for QULIPTA 60 MG TABLET 30S. The total ceiling value of the contract is $1,116.21, with a period of performance through February 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables Cencora,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of QULIPTA 30 MG TABLET 30S, a prescription medication, with a ceiling value of $1,488.28. The contract has an ultimate completion date of May 17, 2024 and was awarded on April 26, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it...
- This federal contract award, valued at $3,607.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product QULIPTA 60 MG TABLET 30S, with a ceiling value of $5,523.86 and a performance period through June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,706.06 contract is for the supply of 4,568,013,877 units of the medication QULIPTA 60 MG TABLET 30S. The award has an ultimate completion date of April 24, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,154.79, is for the supply of the pharmaceutical product QULIPTA 60 MG TABLET 30S. The contract is not set aside and is a firm fixed-price delivery order. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription medication QULIPTA 30 MG TABLET 30S. The contract has a ceiling value of $1,076.53 and a completion date of October 8, 2024. It is a firm fixed-price contract type. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of medications,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ77QDelivery Order
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of the prescription medication QULIPTA 60 MG TABLET 30S, with a total ceiling value of $3,421.01 and a period of performance through October 18, 2023. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 10/17/23 |